Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
TEVA Pharmaceutical Industries Ltd. shares: Harel Insurance Investments & Financial Services Ltd. reported beneficial ownership of 70,418,201 ordinary shares, or 6.0% of the class. Harel reported shared voting power over 69,390,266 shares and shared dispositive power over 70,418,201 shares, with no sole voting or dispositive power.
The reported 6.0% is based on 1,165,296,084 TEVA ordinary shares issued and outstanding as of June 30, 2026. Harel said the reported amount should not be construed as an admission that it beneficially owns more than 1,015,197 shares, which it identified as held for its own account; other reported shares include member and third-party client holdings managed by subsidiaries.
Key Figures
Beneficially owned:70,418,201 ordinary sharesPercent of class:6.0%Shared voting power:69,390,266 ordinary shares+4 more
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting powerregulatory
"Shared Voting Power 69,390,266.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared Dispositive Power 70,418,201.00"
independent voting and investment decisionsregulatory
"makes independent voting and investment decisions"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many TEVA shares did Harel report beneficially owning?
Harel reported beneficial ownership of 70,418,201 TEVA ordinary shares, equal to 6.0% of the class. Harel said this report should not be construed as an admission that it beneficially owns more than 1,015,197 shares.
How much voting and dispositive power did Harel report over TEVA shares?
Harel reported shared voting power over 69,390,266 shares and shared dispositive power over 70,418,201 shares. It reported zero sole voting power and zero sole dispositive power.
How were Harel's reported TEVA shares categorized?
Harel reported 68,375,069 shares held for members of the public through funds, insurance policies and other managed arrangements; 1,027,935 shares in third-party client accounts managed by a subsidiary with no voting power over those shares; and 1,015,197 shares beneficially held for its own account.
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
ISRAEL
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
69,390,266.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
70,418,201.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
70,418,201.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.0 %
12
Type of Reporting Person (See Instructions)
CO
Comment for Type of Reporting Person: * With regard to the date of event that requires filing, see the explanatory note in Item 4.
With regard to Rows (6), (8) and (9), please see Item 4.
Row (11) is based on 1,165,296,084 Ordinary Shares issued and outstanding as of June 30, 2026 (as reported by the Issuer in its Annual Report on Form 10-Q filed with the Securities and Exchange Commission on July 29, 2026).
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
TEVA PHARMACEUTICAL INDUSTRIES LTD.
(b)
Address of issuer's principal executive offices:
124 Dvora Hanevi'a Street, Tel Aviv, Israel, 6944020.
Address or principal business office or, if none, residence:
3 Aba Hillel Street, Ramat Gan 52118, Israel
(c)
Citizenship:
Israel
(d)
Title of class of securities:
Ordinary Shares, par value NIS 0.10 per share
(e)
CUSIP No.:
M8769Q102
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Of the 70,418,201 Ordinary Shares reported in this Statement as beneficially owned by the Reporting Person, (i) 68,375,069 Ordinary Shares are held for members of the public through, among others, provident funds and/or mutual funds and/or pension funds and/or insurance policies and/or exchange traded funds, which are managed by subsidiaries of the Reporting Person, each of which subsidiaries operates under independent management and makes independent voting and investment decisions, (ii) 1,027,935 Ordinary Shares are held by third-party client accounts managed by a subsidiary of the Reporting Person as portfolio managers, which subsidiary operates under independent management and makes independent investment decisions and has no voting power in the securities held in such client accounts, and (iii) 1,015,197 Ordinary Shares are beneficially held for its own account. Consequently, this Statement shall not be construed as an admission by the Reporting Person that it is the beneficial owner of more than 1,015,197 Ordinary Shares covered by this Statement.
(b)
Percent of class:
See Row (11) of the cover page of the Reporting Person above.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
See Row (6) of the cover page of the Reporting Person above and note in Item 4 above.
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
See Row (8) of the cover page of the Reporting Person above and note in Item 4 above.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
